Y-box binding protein-1 expression in diffuse large B-cell lymphoma: an impact on prognosis in the rituximab era. [electronic resource]
Producer: 20110307Description: 2054-62 p. digitalISSN:- 1029-2403
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal, Murine-Derived -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Pharmacological -- metabolism
- Biomarkers, Tumor -- metabolism
- Cyclophosphamide -- therapeutic use
- Doxorubicin -- therapeutic use
- Female
- Humans
- Lymphoma, Large B-Cell, Diffuse -- diagnosis
- Male
- Middle Aged
- Prednisone -- therapeutic use
- Prognosis
- Rituximab
- Survival Analysis
- Vincristine -- therapeutic use
- Y-Box-Binding Protein 1 -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.